Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL
Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.